Value Investing
Value Investing Articles
Sometimes stocks sell off too much, and 24/7 Wall St. wanted to see if Oracle's current stock price is now a value proposition or a value trap.
Published:
Petrobras may still have a slew of problems, but several positive developments have been in the works of late.
Published:
While traditional Dow and S&P 500 stocks are often given upside of 8% to 15% for analysts' Buy and Outperform ratings, some analysts see certain stocks rising 30%, 50% or even 100%.
Published:
Fund managers continue to underweight high-quality mega-cap stocks, particularly those with foreign exposure.
Published:
Oppenheimer's Holden Lewis has reiterated his Outperform rating and $26 price target on ExOne, after remodeling the stock after the company's earnings report earlier in June.
Published:
Energy XXI could have a solid bounce heading its way if Canaccord Genuity is correct in its latest research report.
Published:
What are investors supposed to make of it when they see that Facebook has passed Wal-Mart in total market capitalization?
Published:
Independent research firm Argus has a report out that may indicate that Calpine could be worth literally 50% more than its current price.
Published:
Merger talks within the health insurance sector are reaching a critical point, and it appears that there will be some major moves in the very near future.
Published:
ThinkstockAs we get closer to second quarter earnings, many investors on Wall Street and Main Street are starting to concentrate on having stocks in portfolios that can not only hit or beat the...
Published:
ThinkstockThis past week was exciting, with the Nasdaq finally surpassing its old high from March of 2000 and with the markets trying to price in the impact of a likely Greek exit from the euro. It...
Published:
If you combine sterling balance sheets with strong sector prominence, you then have a recipe for success.
Published:
A fresh report implies that Synergy shares, even after the monumental gain on Wednesday, could actually more than double.
Published:
Both HP and IBM look relatively cheap compared to the market, but a key analyst call from Credit Suisse sees stark differences about in what directions they might be headed.
Published:
24/7 Wall St. cannot help but wonder if it is possible that one of these top health insurance companies could be left without a merger partner.
Published: